RU2020112751A - Отличные от человека животные, у которых экспрессируется гуманизированный комплекс c1q - Google Patents
Отличные от человека животные, у которых экспрессируется гуманизированный комплекс c1q Download PDFInfo
- Publication number
- RU2020112751A RU2020112751A RU2020112751A RU2020112751A RU2020112751A RU 2020112751 A RU2020112751 A RU 2020112751A RU 2020112751 A RU2020112751 A RU 2020112751A RU 2020112751 A RU2020112751 A RU 2020112751A RU 2020112751 A RU2020112751 A RU 2020112751A
- Authority
- RU
- Russia
- Prior art keywords
- polypeptide
- chimeric
- nucleic acid
- rodent
- acid sequence
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title claims 17
- 229920001184 polypeptide Polymers 0.000 claims 139
- 108090000765 processed proteins & peptides Proteins 0.000 claims 139
- 102000004196 processed proteins & peptides Human genes 0.000 claims 139
- 241000283984 Rodentia Species 0.000 claims 119
- 150000007523 nucleic acids Chemical class 0.000 claims 92
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 62
- 150000001413 amino acids Chemical class 0.000 claims 44
- 101150065475 C1QA gene Proteins 0.000 claims 41
- 101150084780 C1qb gene Proteins 0.000 claims 39
- 101150104394 C1qc gene Proteins 0.000 claims 37
- 239000000427 antigen Substances 0.000 claims 31
- 102000036639 antigens Human genes 0.000 claims 31
- 108091007433 antigens Proteins 0.000 claims 31
- 108020004707 nucleic acids Proteins 0.000 claims 30
- 102000039446 nucleic acids Human genes 0.000 claims 30
- 210000004027 cell Anatomy 0.000 claims 25
- 238000000034 method Methods 0.000 claims 19
- 239000002773 nucleotide Substances 0.000 claims 16
- 125000003729 nucleotide group Chemical group 0.000 claims 16
- 108090000623 proteins and genes Proteins 0.000 claims 7
- 241001529936 Murinae Species 0.000 claims 6
- 125000003275 alpha amino acid group Chemical group 0.000 claims 6
- 102000025171 antigen binding proteins Human genes 0.000 claims 5
- 108091000831 antigen binding proteins Proteins 0.000 claims 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 4
- 241000191940 Staphylococcus Species 0.000 claims 4
- 230000001580 bacterial effect Effects 0.000 claims 4
- 102000037865 fusion proteins Human genes 0.000 claims 4
- 108020001507 fusion proteins Proteins 0.000 claims 4
- 102000004169 proteins and genes Human genes 0.000 claims 4
- 101100111903 Mus musculus C1qa gene Proteins 0.000 claims 3
- 101100111913 Mus musculus C1qb gene Proteins 0.000 claims 3
- 101100272890 Mus musculus C1qc gene Proteins 0.000 claims 3
- 101100111905 Rattus norvegicus C1qa gene Proteins 0.000 claims 3
- 101100111914 Rattus norvegicus C1qb gene Proteins 0.000 claims 3
- 101100272891 Rattus norvegicus C1qc gene Proteins 0.000 claims 3
- 241000700605 Viruses Species 0.000 claims 3
- 229940000406 drug candidate Drugs 0.000 claims 3
- 210000002966 serum Anatomy 0.000 claims 3
- 108010076504 Protein Sorting Signals Proteins 0.000 claims 2
- 210000004369 blood Anatomy 0.000 claims 2
- 239000008280 blood Substances 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 230000024203 complement activation Effects 0.000 claims 1
- 230000003013 cytotoxicity Effects 0.000 claims 1
- 231100000135 cytotoxicity Toxicity 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 210000001671 embryonic stem cell Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000005259 measurement Methods 0.000 claims 1
- 229940126601 medicinal product Drugs 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 238000012986 modification Methods 0.000 claims 1
- 230000004048 modification Effects 0.000 claims 1
- 238000011808 rodent model Methods 0.000 claims 1
- 230000008685 targeting Effects 0.000 claims 1
- 230000009261 transgenic effect Effects 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/472—Complement proteins, e.g. anaphylatoxin, C3a, C5a
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
- A01K2217/054—Animals comprising random inserted nucleic acids (transgenic) inducing loss of function
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0337—Animal models for infectious diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/035—Animal model for multifactorial diseases
- A01K2267/0368—Animal model for inflammation
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/035—Animal model for multifactorial diseases
- A01K2267/0387—Animal model for diseases of the immune system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
- C12N2015/8527—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic for producing animal models, e.g. for tests or diseases
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Environmental Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Animal Husbandry (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762565438P | 2017-09-29 | 2017-09-29 | |
| US62/565,438 | 2017-09-29 | ||
| PCT/US2018/053099 WO2019067706A1 (en) | 2017-09-29 | 2018-09-27 | NON-HUMAN ANIMALS EXPRESSING A HUMANIZED C1Q COMPLEX |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2020112751A true RU2020112751A (ru) | 2021-10-29 |
| RU2020112751A3 RU2020112751A3 (https=) | 2022-02-09 |
Family
ID=63858187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2020112751A RU2020112751A (ru) | 2017-09-29 | 2018-09-27 | Отличные от человека животные, у которых экспрессируется гуманизированный комплекс c1q |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US11186848B2 (https=) |
| EP (2) | EP3687287B1 (https=) |
| JP (2) | JP7242650B2 (https=) |
| KR (2) | KR102696334B1 (https=) |
| CN (2) | CN111386039B (https=) |
| AU (1) | AU2018341685A1 (https=) |
| CA (1) | CA3077418A1 (https=) |
| DK (1) | DK3687287T5 (https=) |
| ES (1) | ES2961713T3 (https=) |
| FI (1) | FI3687287T3 (https=) |
| IL (1) | IL273588A (https=) |
| LT (1) | LT3687287T (https=) |
| PT (1) | PT3687287T (https=) |
| RU (1) | RU2020112751A (https=) |
| SG (1) | SG11202002002XA (https=) |
| SI (1) | SI3687287T1 (https=) |
| WO (1) | WO2019067706A1 (https=) |
| ZA (1) | ZA202001389B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX394999B (es) | 2017-09-29 | 2025-03-24 | Regeneron Pharma | Animales no humanos que comprenden un locus ttr humanizado y metodos de uso |
| US11891618B2 (en) | 2019-06-04 | 2024-02-06 | Regeneron Pharmaceuticals, Inc. | Mouse comprising a humanized TTR locus with a beta-slip mutation and methods of use |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030082546A1 (en) * | 1996-11-06 | 2003-05-01 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US6586251B2 (en) | 2000-10-31 | 2003-07-01 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| ES2329012T3 (es) | 2000-11-07 | 2009-11-20 | Zymogenetics, Inc. | Receptor del factor de necrosis tumoral humano. |
| GB0322998D0 (en) | 2003-10-01 | 2003-11-05 | Ares Trading Sa | Protein |
| AU2005295269B2 (en) | 2004-10-19 | 2010-05-13 | Regeneron Pharmaceuticals, Inc. | Method for generating an animal homozygous for a genetic modification |
| SI1962895T1 (sl) * | 2005-12-16 | 2013-04-30 | Regeneron Pharmaceuticals, Inc. | Terapevtska uporaba DII4 antagonista in VEGF inhibitorja za inhibiranje tumorske rasti |
| PL2170389T3 (pl) * | 2007-06-12 | 2015-03-31 | Ac Immune Sa | Humanizowane przeciwciało przeciw amyloidowi beta |
| KR102203727B1 (ko) * | 2010-03-31 | 2021-01-18 | 아블렉시스, 엘엘씨 | 키메라 항체의 제조를 위한 비-인간 동물의 유전적 조작 |
| US9283271B2 (en) * | 2010-12-17 | 2016-03-15 | Neurimmune Holding Ag | Human anti-SOD1 antibodies |
| US9043996B2 (en) * | 2011-10-28 | 2015-06-02 | Regeneron Pharmaceuticals, Inc. | Genetically modified major histocompatibility complex animals |
| SI2770821T1 (en) | 2011-10-28 | 2018-01-31 | Regeneron Pharmaceuticals, Inc. | Genetically modified major histocompatibility complex of mice |
| FR2996561B1 (fr) | 2012-10-09 | 2016-03-18 | Commissariat Energie Atomique | Procede de preparation de proteine c1q recombinante |
| MX2015010841A (es) | 2013-02-20 | 2016-05-09 | Regeneron Pharma | Modificacion genetica de ratas. |
| SI2986729T1 (sl) | 2013-04-16 | 2019-02-28 | Regeneron Pharmaceuticals, Inc. | Ciljana sprememba genoma podgane |
| WO2015006507A1 (en) * | 2013-07-09 | 2015-01-15 | Annexon, Inc. | Methods of treatment for alzheimer's disease and huntington's disease |
| SG10202003996YA (en) | 2014-05-05 | 2020-06-29 | Regeneron Pharma | Humanized c5 and c3 animals |
| RU2020122439A (ru) | 2014-11-24 | 2020-09-24 | Регенерон Фармасьютикалз, Инк. | Не относящиеся к человеку животные, экспрессирующие гуманизированный комплекс cd3 |
| MX394999B (es) | 2017-09-29 | 2025-03-24 | Regeneron Pharma | Animales no humanos que comprenden un locus ttr humanizado y metodos de uso |
-
2018
- 2018-09-27 PT PT187866116T patent/PT3687287T/pt unknown
- 2018-09-27 SI SI201831001T patent/SI3687287T1/sl unknown
- 2018-09-27 LT LTEPPCT/US2018/053099T patent/LT3687287T/lt unknown
- 2018-09-27 SG SG11202002002XA patent/SG11202002002XA/en unknown
- 2018-09-27 KR KR1020207011761A patent/KR102696334B1/ko active Active
- 2018-09-27 DK DK18786611.6T patent/DK3687287T5/da active
- 2018-09-27 CN CN201880066080.7A patent/CN111386039B/zh active Active
- 2018-09-27 US US16/144,156 patent/US11186848B2/en active Active
- 2018-09-27 WO PCT/US2018/053099 patent/WO2019067706A1/en not_active Ceased
- 2018-09-27 ES ES18786611T patent/ES2961713T3/es active Active
- 2018-09-27 RU RU2020112751A patent/RU2020112751A/ru unknown
- 2018-09-27 EP EP18786611.6A patent/EP3687287B1/en active Active
- 2018-09-27 JP JP2020518013A patent/JP7242650B2/ja active Active
- 2018-09-27 CA CA3077418A patent/CA3077418A1/en active Pending
- 2018-09-27 KR KR1020247027156A patent/KR20240128129A/ko active Pending
- 2018-09-27 CN CN202310113182.2A patent/CN116376973A/zh active Pending
- 2018-09-27 FI FIEP18786611.6T patent/FI3687287T3/fi active
- 2018-09-27 EP EP23174310.5A patent/EP4249502A3/en not_active Withdrawn
- 2018-09-27 AU AU2018341685A patent/AU2018341685A1/en not_active Abandoned
-
2020
- 2020-03-04 ZA ZA2020/01389A patent/ZA202001389B/en unknown
- 2020-03-25 IL IL273588A patent/IL273588A/en unknown
-
2021
- 2021-10-21 US US17/506,730 patent/US20220033847A1/en not_active Abandoned
-
2023
- 2023-03-08 JP JP2023035499A patent/JP7534465B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2023075230A (ja) | 2023-05-30 |
| CN116376973A (zh) | 2023-07-04 |
| ZA202001389B (en) | 2024-01-31 |
| DK3687287T5 (da) | 2024-08-26 |
| EP4249502A2 (en) | 2023-09-27 |
| RU2020112751A3 (https=) | 2022-02-09 |
| KR20240128129A (ko) | 2024-08-23 |
| CN111386039A (zh) | 2020-07-07 |
| KR20200058487A (ko) | 2020-05-27 |
| CA3077418A1 (en) | 2019-04-04 |
| ES2961713T3 (es) | 2024-03-13 |
| SI3687287T1 (sl) | 2023-11-30 |
| JP7242650B2 (ja) | 2023-03-20 |
| US20220033847A1 (en) | 2022-02-03 |
| EP3687287A1 (en) | 2020-08-05 |
| KR102696334B1 (ko) | 2024-08-21 |
| FI3687287T3 (fi) | 2023-10-12 |
| EP4249502A3 (en) | 2023-12-06 |
| US20190100772A1 (en) | 2019-04-04 |
| IL273588A (en) | 2020-05-31 |
| DK3687287T3 (da) | 2023-10-16 |
| EP3687287B1 (en) | 2023-07-12 |
| PT3687287T (pt) | 2023-11-03 |
| WO2019067706A1 (en) | 2019-04-04 |
| WO2019067706A4 (en) | 2019-05-23 |
| CN111386039B (zh) | 2023-02-28 |
| JP7534465B2 (ja) | 2024-08-14 |
| SG11202002002XA (en) | 2020-04-29 |
| LT3687287T (lt) | 2023-10-25 |
| AU2018341685A1 (en) | 2020-04-02 |
| JP2020535815A (ja) | 2020-12-10 |
| US11186848B2 (en) | 2021-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2020270507B2 (en) | Chimeric antigen receptors, compositions, and methods | |
| KR102213535B1 (ko) | pH-민감성 면역글로불린 서열을 발현하는 비-사람 동물 | |
| JP5142265B2 (ja) | 抗モータリン抗体のパラトープ及びエピトープ | |
| CN103992405A (zh) | 抗-vegf抗体 | |
| US20220174920A1 (en) | Non-human animals having an immunoglobulin heavy chain variable region that includes an engineered diversity cluster and uses thereof | |
| CN116601164A (zh) | 靶向hiv的ww结构域激活的细胞外囊泡 | |
| RU2020112751A (ru) | Отличные от человека животные, у которых экспрессируется гуманизированный комплекс c1q | |
| JP2020535815A5 (https=) | ||
| KR20240099405A (ko) | 단백질 검출 방법 및 단백질 검출용 조성물 | |
| KR101972899B1 (ko) | 소수성 테일 도메인이 제거된 먹장어 유래 VLRB 단백질과 C4bp 올리고머화 도메인이 연결된 융합 단백질 및 이의 용도 | |
| JP7117088B2 (ja) | 抗体及びその製造方法、並びに抗体の熱安定性を向上させる方法 | |
| WO2022148491A1 (zh) | 一种可组装蛋白原件及其用途 | |
| US20230232796A1 (en) | Non-human animals comprising a humanized ace2 locus | |
| CN102033057A (zh) | 基于多功能聚合物和荧光共振能量转移的抗体检测方法 | |
| JP2020534797A (ja) | リガンド指向型抗体設計の方法及び組成物 | |
| US20240131200A1 (en) | Reporter protein fused antibodies | |
| KR20250022132A (ko) | 동물 모델과 치료 분자 | |
| TWI698643B (zh) | 用於檢測米田堡血型抗原的抗體及其片段、試劑盒及方法 | |
| CN117279937A (zh) | Epcam结合分子及其用途 | |
| CN111876476A (zh) | 用于扩增马抗体的巢式pcr引物、试剂盒及其应用 | |
| CN121930336A (zh) | 一种鉴别诊断猪蓝耳病毒gp5蛋白谱系1和谱系8的单克隆抗体 | |
| CN116867804A (zh) | 间皮素结合分子及其用途 | |
| TW202313681A (zh) | Ｍａｇｅｂ２結合構建體 | |
| CN121949570A (zh) | 一种能够同时识别猪蓝耳病毒gp5蛋白多个谱系的单克隆抗体 | |
| CN116916956A (zh) | Fap结合分子及其用途 |